BCL2 and hepatocellular carcinoma: The results showed that cell viability increased, and the pro-apoptotic proteins Bax and cleaved Caspase-3 decreased, while the anti-apoptotic protein Bcl-2 increased in MTS-driven mito-COX-2-overexpressing HCC cells (Figure S4A,B).